These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 17498182

  • 1. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM, Burakov AM, Tsoy MV, Egorova VY, Slavina TY, Grinenko AY, Zvartau EE, Woody GE.
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [Abstract] [Full Text] [Related]

  • 2. Challenges to antagonist blockade during sustained-release naltrexone treatment.
    Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Gossop M, Hegstad S, Kristensen Ø, Waal H.
    Addiction; 2010 Sep; 105(9):1633-9. PubMed ID: 20707781
    [Abstract] [Full Text] [Related]

  • 3. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK, Morris N, Arnold-Reed D, Tait RJ.
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [Abstract] [Full Text] [Related]

  • 4. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Krupitsky EM, Zvartau EE, Masalov DV, Tsoy MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE.
    J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Fishman M.
    Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Naltrexone implants.
    Kelly KI, McBride A.
    Br J Psychiatry; 2010 Jan; 196(1):77; author reply 77. PubMed ID: 20044669
    [No Abstract] [Full Text] [Related]

  • 9. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
    Foster J, Brewer C, Steele T.
    Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D, Koutsogiannis Z, Kronborg I.
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [Abstract] [Full Text] [Related]

  • 13. Unintentional rapid opioid detoxification: case report.
    Singh SM, Sharma B.
    Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases.
    Brewer C.
    Addict Biol; 2002 Jul; 7(3):321-3. PubMed ID: 12126492
    [Abstract] [Full Text] [Related]

  • 18. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE, O'Neil P, Holman CD, Bulsara MK, Rodiguez C, Gawthorne G, Tait RJ, Hulse GK.
    Am J Drug Alcohol Abuse; 2007 Jul; 33(5):655-64. PubMed ID: 17891658
    [Abstract] [Full Text] [Related]

  • 19. Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature.
    Brewer C, Wong VS.
    Addict Biol; 2004 Mar; 9(1):81-7. PubMed ID: 15203443
    [Abstract] [Full Text] [Related]

  • 20. Haight-Ashbury free clinics' drug detoxification protocols--Part 2: Opioid blockade.
    Galloway G, Hayner G.
    J Psychoactive Drugs; 1993 Mar; 25(3):251-2. PubMed ID: 8258763
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.